SyMRI 15 from SyntheticMR transforms traditional imaging methodologies with its advanced synthetic imaging technology. It’s been clinically validated in extensive multi-center studies across leading U.S. institutions and has now gained FDA 510(k) clearance. 👏 Congratulations to acting CEO Vedran Beglerbegovic and the rest of the team! 🔗 Read more: https://lnkd.in/dqT5VSHg 📰 Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/dseC4SiU #MedicalDevices #MedicalEquipment #HealthTech #Headhunter #TalentManagement #Leadership #LeadershipDevelopment #GuidedSolutions #ExecutiveSearch #Executive #Csuite #MedTechExecutiveSearch
Guided Solutions’ Post
More Relevant Posts
-
Diagnostic Imaging Market Anticipated to reach $34.6 billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://lnkd.in/gcUZsXqs The global diagnostic imaging market in terms of revenue was estimated to be worth $26.5 billion in 2023 and is poised to reach $34.6 billion by 2028, growing at a CAGR of 5.5% from 2023 to 2028. 𝐌𝐚𝐢𝐧 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: General Electric Company Siemens Healthineers Canon Medical Systems Corporation Hitachi FUJIFILM Holdings Corporation Carestream Hologic, Inc. SHIMADZU CORPORATION Agfa-Gevaert S.A. Esaote Planmed Shenzhen Anke High-Tech Co.,Ltd.. NEUSOFT MEDICAL SYSTEMS, USA, INC. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. KONICA MINOLTA, INC. Analogic Toshiba America Medical Systems Medtronic Bracco Imaging do Brasil Guerbet Lantheus Bayer Consumer Care AG Terumo Medical Corporation Medi Physics Lantheus Medical Imaging IncLantheus MI Australia Pty Ltd, Bracco Guerbet Bayer HealthCare Manufacturing S.r.l. Terumo Medical Corporation
To view or add a comment, sign in
-
GE HealthCare for the third consecutive year, has topped a U.S. FDA list of #AI enabled medical devices with 72 listed 510(k) clearances or authorizations to date in the U.S. By harnessing the power of AI, we’re tackling the industry’s toughest challenges – including data overload, physician burnout, and operational inefficiencies. Learn more today on our full portfolio of AI-enabled medical device and enterprise digital solutions! #GEHealthCare #PrecisionMedicine
GE HealthCare Tops List for Third Year in a Row with Highest Number of AI-Enabled Medical Device Authorizations
businesswire.com
To view or add a comment, sign in
-
The Australian Medtech Manufacturing Alliance (AMMA) has welcomed Pathology Technology Australia (PTA), AHSPO, and the Medical Technology Association of Australia (MTAA) as new steering group members. #MedTech #Collaboration #Innovation https://lnkd.in/gT48yh_S
New members join forces to advance local medtech manufacturing - Australian Manufacturing
https://www.australianmanufacturing.com.au
To view or add a comment, sign in
-
MedTech wants wiggle room for innovation. Bravo, AdvaMed... Continued advocacy and awareness helps. This requires implementing new tech ie AI to bring us into the future of medical devices. The future of medtech and sales is going to be really interesting... 📈 #MedTech #MedicalDevices #Sales #MedSales
AdvaMed’s Imaging Division is Fast Out of Gates at the Medtech Association - AdvaMed
advamed.org
To view or add a comment, sign in
-
Learn how HALO AP Dx automatically organizes images, metadata, gross details, and patient information into cases, facilitates case prioritization and sign-out, and enables ergonomic image navigation. See common anatomic pathology workflows in action and discover how HALO AP Dx modernizes tumor boards and promotes streamlined management of clinical trials.
In line with the news that Indica Labs received FDA clearance for HALO AP Dx, the Indica team has organized a 1-hour webinar to introduce HALO AP Dx and demonstrate how the platform can be used for comprehensive workflows in primary diagnostics. This 510(k) clearance allows HALO AP Dx to be utilized in conjunction with the Hamamatsu NanoZoomer® S360MD Slide scanner for in-vitro diagnostic use and sets the stage for use with additional FDA-cleared slide scanners in the future. The webinar will take place on June 13th, 8 am PDT | 16:00 UK, and will be presented by Indica's very own Chief Operating Officer, Eric Runde. #digitalpathology #pathologynews #webinar
Introducing HALO AP Dx: An Enterprise Pathology Platform for Primary Diagnosis | June 13
https://www.pathologynews.com
To view or add a comment, sign in
-
Implement the newest MedTech trends with the automated BPAMedical365®, https://lnkd.in/dUkTS5PZ ⭐ MedTech Marvels 2024: 24 MedTech Trends to Watch in 2024, https://lnkd.in/dff_8Pyi #medtech #iso13485 #regulatoryaffairs #qualitymanagement #eQMS
MedTech Marvels 2024: 24 MedTech Trends to Watch in 2024
medtechspectrum.com
To view or add a comment, sign in
-
In anticipation of Signify Research’s soon-to-be-published fourth iteration of its 'Digital Pathology – World – 2024' market report, our expert author Imogen Fitt reviews her January 2024 market predictions in a series of videos. In this edition, she highlights a surge in FDA approvals for end-to-end solutions, emphasising the necessity of this for success in the US clinical market. While growth in the States is robust widespread adoption will also hinge on establishing a clear ROI for digitisation, likely through reimbursement. So far this year there have been 7 FDA approvals for Digital pathology including: 1 - Proscia-Hamamatsu Corporation 2 - Hologic, Inc. 3 - Indica Labs-Hamamatsu Corporation 4 - Scopio Labs 5 - Roche 6 - Philips 7 - Leica Biosystems-Sectra To discuss what this means for your business connect with Imogen or visit https://lnkd.in/ecDYyQ_p. #digitalPathology #FDAap #marketintelligence #medicaltech
Digital Pathology 2024 Review Pt1 | Featuring Imogen Fitt, Senior Analyst | Signify Research
To view or add a comment, sign in
-
Click below to hear my thoughts on what all these recent #fdaapprovals mean for the #digitalpathology market!
In anticipation of Signify Research’s soon-to-be-published fourth iteration of its 'Digital Pathology – World – 2024' market report, our expert author Imogen Fitt reviews her January 2024 market predictions in a series of videos. In this edition, she highlights a surge in FDA approvals for end-to-end solutions, emphasising the necessity of this for success in the US clinical market. While growth in the States is robust widespread adoption will also hinge on establishing a clear ROI for digitisation, likely through reimbursement. So far this year there have been 7 FDA approvals for Digital pathology including: 1 - Proscia-Hamamatsu Corporation 2 - Hologic, Inc. 3 - Indica Labs-Hamamatsu Corporation 4 - Scopio Labs 5 - Roche 6 - Philips 7 - Leica Biosystems-Sectra To discuss what this means for your business connect with Imogen or visit https://lnkd.in/ecDYyQ_p. #digitalPathology #FDAap #marketintelligence #medicaltech
Digital Pathology 2024 Review Pt1 | Featuring Imogen Fitt, Senior Analyst | Signify Research
To view or add a comment, sign in
-
Wow, again. SS Innovations has its foot on the gas pedal. Shocking news, to be honest, but an FDA approval next year would leapfrog Mantra 3 past Johnson & Johnson by years. Medtronic is still expected to file an IDE by the end of 2024 so it could still be second behind Intuitive but I'm not sure what that gets you. SS Innovations, if approved, could compete vigorously on price as it's selling its system for far less than Intuitive and the other US players. #surgicalrobotics #roboticsurgery #medtech #medicaldevices #medicaldevice
SS Innovations expects FDA approval for surgical robot by the end of 2025
https://www.massdevice.com
To view or add a comment, sign in
-
Microbot Medical recently announced that it has submitted a 510(k) premarket notification to the US Food and Drug Administration for its Liberty endovascular robotic system. Read more: https://lnkd.in/eG96Z-Xc
Microbot Medical announces US FDA submission for commercialisation of Liberty endovascular robotic system - Vascular News
vascularnews.com
To view or add a comment, sign in
96,245 followers